The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -54.14%.However, over the last six months, we can see a stronger performance of -48.99%. Over the last 30 days, the price of APLS has leaped by -33.13%. And in the last five days, it has fallen by -4.82%.
Apellis Pharmaceuticals Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $73.80 on 01/09/24, while the lowest price for the same duration was marked at $26.69 on 10/02/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of APLS Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Apellis Pharmaceuticals Inc’s current trading price is -62.80% away from its 52-week high, while its distance from the 52-week low is 2.85%. The stock’s price range during this period has varied between$26.69 and $73.80. The Apellis Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 6.65 million for the day, a figure considerably higher than their average daily volume of 1.82 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Apellis Pharmaceuticals Inc (APLS) has experienced a quarterly decline of -26.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.34B and boasts a workforce of 706 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 37.78, with a change in price of -13.75. Similarly, Apellis Pharmaceuticals Inc recorded 1,705,432 in trading volume during the last 100 days, posting a change of -33.37%.
APLS’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for APLS stands at 1.80. Similarly, the long-term debt-to-equity ratio is also 1.77.
APLS Stock Stochastic Average
As of today, Apellis Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 4.98%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 5.44%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 6.60% and 7.98%, respectively.
